SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CEO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.
“We’re releasing a probiotic supplement that, when absorbed through the gut-skin axis, can be beneficial for the skin. However, the science behind it is very complex, so we needed to create three 30-second standalone videos that simplified the science behind our product. Still, we didn’t want to simplify it too much because we had a broad audience ranging from patients to scientific academics, analysts, and investors.”
“We’re releasing a probiotic supplement that, when absorbed through the gut-skin axis, can be beneficial for the skin. However, the science behind it is very complex, so we needed to create three 30-second standalone videos that simplified the science behind our product. Still, we didn’t want to simplify it too much because we had a broad audience ranging from patients to scientific academics, analysts, and investors.”
“The result was phenomenal. The videos are easy to understand and the animation is anatomically accurate. Our entire board said the videos were flawless and wanted to upload them to our website immediately. On top of that, our target audience has been impressed — professors of biomedicine, anatomy, and dermatology recognized how good our video is.”